Navigate: Home|Posts by Ockham Research

Ockham Research

Ockham Research is an independent equity research provider based in Atlanta, Georgia. Security analysis at Ockham Research is based upon the principle known as Ockham's Razor, named for the 14th- century Franciscan friar, William of Ockham. The principle states that a useful theory should utilize as few elements as possible, because efficiency is valuable. In this spirit, our goal is to make the investing environment as simple and understandable as possible, yet no simpler than is necessary.

We utilize this straightforward approach to value over 5500 securities, with key emphasis given to the study of individual securities' price-to-sales, price-to-cash earnings and other historical valuation ranges. Our long term value investing methodology is powered by the teachings of Ben Graham and it has proven to be very adept at identifying stock prices that are out of line with fundamental factors.

Ockham Research provides its research in a variety of forms and products including our company specific reports, portfolio analytics tools, newsletters, and blog posts. We also offer a white labeling research solution that can give any financial services firm their own research presence without the time and cost associated with building such a robust coverage universe of their own.

Visit: Ockham Research




Ockham Research's Latest Articles | 539

Investors May Want to Give a Toast to PepsiCo

Mar 15, 2010| 

The world’s second largest soft drink maker, PepsiCo. (PEP), announced a share repurchase program that could amount to $15 billion over the next three years. ... Read »

Terra Industries Eventually Found Its Dance Partner

Mar 12, 2010| 

After more than a year of bidding Terra Industries (TRA) has finally agreed to combine with CF Industries (CF). The long, drawn out bidding process involved another... Read »

The Massive Rise in Federal Debt

Mar 11, 2010| 

The startling graphic below shows the change in debt outstanding by sector as a percentage of GDP over the past 30 years. This data was compiled by the good folks... Read »

Don’t Get Caught Up in the Hype

Mar 11, 2010| 

Imax (IMAX), which operates giant screened movie theatres as well as licenses the technologies to third parties, reported an outstanding fiscal fourth quarter 2009... Read »

Allergan Gets FDA Approval: Botox Has a Medical Use?!

Mar 10, 2010| 

Allergan (AGN) received approval from the FDA on Tuesday for a Botox treatment of stiffness in elbows, wrists and fingers in adults, a condition known as spasticity.... Read »

Cramer Abandons Ship on Blue Chip Oil Stocks

Mar 10, 2010| 1

“…Now, after that is Exxon, off 2.1% since the year began. This petro-giant is totally problematic. No great yield. Nothing new until the XTO, that natural gas... Read »

The Ride Higher Runs Out of Gas

Mar 9, 2010| 

Following second quarter results that showed further improvement from a year ago, Thor Industries (THO) stock retreated nearly 8% on Tuesday because it was not as... Read »

Sprint Sees Growth Ahead and Vows to Get Aggressive on Debt

Mar 8, 2010| 

Sprint Nextel (S) is getting a boost today after announcing that it will continue strict cost management in an effort to aggressively pay down debt. During a discussion... Read »

Credit Noose Loosens

Mar 5, 2010| 

In an encouraging sign for the US economy, consumer credit availability actually expanded in January. Economists had expected consumer credit to contract yet again... Read »

Video Game Wars Heat Up in Courtroom Battle

Mar 5, 2010| 

It has been a news-filled week at video game publisher Activision Blizzard (ATVI) as they fired two top executives at Infinity Ward, the subsidiary responsible for... Read »

12345»Last »